It will sell 28.2m shares, representing around 6% of Aspen. The shares closed at Z267.40 on Monday night.
The deal will leave GSK with 13% of Aspen. GSK will retain its seat on the board and commit to a six month lock-up on that stake.Citi and UBS ...
Please take a trial or subscribe to access this content.
Contact Mark Goodes to discuss your access: email@example.com